Studies have shown that SPRR1B is abnormally high expressed in a variety of solid tumors (such as esophageal cancer, head and neck squamous cell carcinoma), and promotes tumor invasion and metastasis by activating signaling pathways such as EGFR/MAPK (23, 28–30). Here, SPRR1B is linked to neoplasm.